Study of Cetuximab to Treat Gastric Cancer
NCT00699881
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
61
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
cetuximab
Sponsor
Fudan University